WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006084226) ANTIBODIES THAT BIND TO EPHA2 AND METHODS OF USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084226    International Application No.:    PCT/US2006/004057
Publication Date: 10.08.2006 International Filing Date: 06.02.2006
IPC:
C07K 16/00 (2006.01), A61K 39/395 (2006.01), C12P 21/04 (2006.01), C12N 5/16 (2006.01), C07H 21/04 (2006.01), C12N 5/06 (2006.01), C07H 21/02 (2006.01)
Applicants: RAVEN BIOTECHNOLOGIES, INC. [US/US]; Britannia Oyster Point, 1140 Veterans Blvd., South San Francisco, California 94080 (US) (For All Designated States Except US).
MATHER, Jennie, P. [US/US]; (US) (For US Only).
ROBERTS, Penelope, E. [US/US]; (US) (For US Only)
Inventors: MATHER, Jennie, P.; (US).
ROBERTS, Penelope, E.; (US)
Agent: ZHOU, Jie; Morrison & Foerster LLP, 755 Page Mill Road, Palo Alto, California 94304-1018 (US)
Priority Data:
60/650,047 04.02.2005 US
Title (EN) ANTIBODIES THAT BIND TO EPHA2 AND METHODS OF USE THEREOF
(FR) ANTICORPS SE LIANT A EPHA2 ET PROCEDES D'UTILISATION DE CEUX-CI
Abstract: front page image
(EN)Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed.
(FR)L'invention concerne la mise au point et la caractérisation d'un anticorps qui se lie à l'antigène EphA2, lequel antigène est présent dans divers cancers humains tels que le cancer du sein, du poumon, de la prostate et du côlon. Par ailleurs, l'invention concerne des méthodes de diagnostic et de traitement de divers types de cancers au moyen de ces anticorps dirigés contre l'antigène dont il est question.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)